WI Alpha 9 ApS: Financial statements 2022
CVR: 36938587
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
WI Alpha 9 ApS (CVR 36938587) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -207,838,000 compared with DKK -594,848,000 the year before. Equity in the 2022 report amounted to DKK 159,314,000. The solvency ratio was 99.7%.
- Profit/Loss
- DKK -207,838,000
- Equity
- DKK 159,314,000
- Total Assets
- DKK 159,738,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -207.8 mio. | 159.3 mio. | - |
| 2021 | - | - | -594.8 mio. | 367.2 mio. | - |
| 2020 | - | - | 292.3 mio. | 963 mio. | - |
| 2019 | - | - | 243.8 mio. | 670.7 mio. | - |
| 2018 | - | - | 363.5 mio. | 426.9 mio. | - |
Official annual report
Keep an eye on WI Alpha 9 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
WI Alpha 9 ApS has published its annual report for 2021. The net result was DKK -594,848,000.
About WI Alpha 9 ApS
WI Alpha 9 ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Weco Biotech ApS. The management consists of Rasmus Lund-Jacobsen. The company is owned by WECO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -83,000 and a net result of DKK -542,000 compared with DKK 35,061,000 the year before. Equity in the 2025 report amounted to DKK 229,113,000.